Flex Pharma Presenting at Upcoming Investor Conferences in June 2017
May 30 2017 - 9:23AM
Business Wire
Click to Tweet
Flex Pharma, Inc. (NASDAQ: FLKS), a clinical-stage biotechnology
company that is developing innovative and proprietary treatments
for cramps and spasticity associated with severe neurological
diseases including amyotrophic lateral sclerosis (ALS), multiple
sclerosis (MS) and Charcot-Marie-Tooth (CMT), today announced that
it will present at the following upcoming investor conferences in
June:
- The Jefferies Global Healthcare
Conference on June 6, 2017 at 2:30 pm ET in New York, NY;
- The JMP Securities Life Science
Conference on June 20, 2017 at 2:00 pm ET in New York, NY.
A live webcast of Flex Pharma’s presentations at these
conferences may be accessed in the Investor section of the
Company’s website at www.flex-pharma.com. Please log on to the Flex
Pharma website approximately 15 minutes prior to the scheduled
webcast to ensure adequate time for any software downloads that may
be required. A replay of the webcast will be available on Flex
Pharma’s website for 2 weeks following each presentation.
About Flex Pharma
Flex Pharma, Inc. is a clinical-stage biotechnology company that
is developing innovative and proprietary treatments for cramps and
spasticity associated with the severe neurological diseases
including ALS, MS and Charcot-Marie-Tooth (CMT). Flex Pharma was
founded by National Academy of Science members Rod MacKinnon, M.D.
(2003 Nobel Laureate), and Bruce Bean, Ph.D., recognized leaders in
the fields of ion channels and neurobiology, along with Chair and
CEO Christoph Westphal, M.D., Ph.D.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170530005689/en/
Flex Pharma, Inc.Elizabeth Woo, 617-874-1829SVP, Investor
Relations & Corporate Communicationsirdept@flex-pharma.com
FLEX PHARMA, INC. (NASDAQ:FLKS)
Historical Stock Chart
From Mar 2024 to Apr 2024
FLEX PHARMA, INC. (NASDAQ:FLKS)
Historical Stock Chart
From Apr 2023 to Apr 2024